RTW Investments, LP 13D/13G Filings for Sage Therapeutics, Inc. (SAGE)

RTW Investments, LP 13D and 13G filings for Sage Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
09:00 am
Sale
2024-12-31 13G Sage Therapeutics, Inc.
SAGE
RTW Investments, LP 3,002,370
4.900%
-2,194,649decrease
(-42.23%)
Filing
2024-02-14
07:09 am
Purchase
2023-12-31 13G Sage Therapeutics, Inc.
SAGE
RTW Investments, LP 5,197,019
8.700%
5,197,019increase
(New Position)
Filing